Epirubicin and white blood cell count decreased Patient Reports March 21, 2010

Epirubicin Side Effects Report #5409028-6
Epirubicin side effect was reported by a Health Professional from UNITED STATES on July 26, 2007. Male patient, 74 years of age, was diagnosed with oesophageal adenocarcinoma and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: anaemia, bone marrow failure, rash pruritic, thrombocytopenia, white blood cell count decreased. Epirubicin dosage: unknown. During the same period patient was treated with METHOTREXATE, MITOMYCIN, ETOPOSIDE, FLUOROURACIL, PROLEUKIN, LEUCOVORIN CALCIUM. Patient recovered.

Epirubicin Side Effects Report #6030244-7
Epirubicin side effect was reported by a Physician from JAPAN on Dec 24, 2008. Female patient was diagnosed with hepatic neoplasm malignant and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: ascites, jaundice , platelet count decreased, white blood cell count decreased. Epirubicin dosage: 30 MG, UNK. During the same period patient was treated with MITOMYCIN, CISPLATIN, FLUOROURACIL. Patient recovered.

Epirubicin Side Effects Report #4949999-5
Epirubicin side effect was reported by a Health Professional from UNITED KINGDOM on Mar 02, 2006. Male patient, 69 years of age, weighting 143.3 lb, was diagnosed with gastric cancer and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: dyspnoea, lethargy, malaise, neutropenic sepsis, pyrexia, white blood cell count decreased. Epirubicin dosage: 100 MG, CYCLIC, INTRAVENOUS. During the same period patient was treated with CISPLATIN, CAPECITABINE, DOMPERIDONE. Patient recovered.

Epirubicin Side Effects Report #4850729-6
Epirubicin side effect was reported by a Physician from JAPAN on Nov 25, 2005. Female patient, 53 years of age, was diagnosed with breast cancer recurrent and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: cardiac failure, lymphangiosis carcinomatosa, neutropenia, respiratory failure, white blood cell count decreased. Epirubicin dosage: 75M/MG2 INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, HYSRON. Patient died on 11/08/2005.


Epirubicin Side Effects Report #5104079-3
Epirubicin side effect was reported by a Physician from JAPAN on Aug 29, 2006. Female patient, 60 years of age, weighting 114.6 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: interstitial lung disease, lung disorder, neutrophil count decreased, white blood cell count decreased. Epirubicin dosage: 90 MG (90 MG, FREQUENCY: QD) INTRAVENOUS. During the same period patient was treated with FLUOROURACIL, CYCLOPHOSPHAMIDE. Patient recovered.

Epirubicin Side Effects Report #5170628-2
Epirubicin side effect was reported by a Physician from JAPAN on Nov 20, 2006. Female patient, 59 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: hepatic function abnormal, interstitial lung disease, vasculitis , white blood cell count decreased. Epirubicin dosage: 25 MG MG/M*2 (WEEKLY). During the same period patient was treated with DOCETAXEL. Patient recovered.

Epirubicin Side Effects Report #4847432-5
Epirubicin side effect was reported by a Health Professional from UNITED STATES on Nov 21, 2005. Female patient, 57 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: febrile neutropenia, fluid overload, haemoglobin decreased, hypotension, platelet count decreased, pleural effusion, pneumonia , white blood cell count decreased, white blood cell count increased. Epirubicin dosage: (100 MG/M2, CYCLE 1 OUT OF 4, EVERY 3 WEEKS), INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL, AVELOX, NEUPOGEN, PRILOSEC, ZOFRAN, CARAFATE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4576725-4
Epirubicin side effect was reported by a Physician from on Jan 24, 2005. Female patient, 56 years of age, weighting 225.0 lb, was diagnosed with breast cancer , anaemia of malignant disease and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: asthenia, blood potassium decreased, haematocrit decreased, haemoglobin decreased, polydipsia, white blood cell count decreased. Epirubicin dosage: 1500 MG (1 IN 21 D), INTRAVENOUS. During the same period patient was treated with CYCLOPHOSPHAMIDE, DOCETAXEL, DARBEPOETIN ALFA, DARBEPOETIN ALFA, ERYTHROPOIETIN. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5099700-2
Epirubicin side effect was reported by a Health Professional from AUSTRALIA on Aug 23, 2006. Female patient, 44 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: bacterial infection , blood culture positive, neutrophil count decreased, white blood cell count decreased. Epirubicin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL, TRIPTORELIN ACETATE. Patient was hospitalized. Patient recovered.


Epirubicin Side Effects Report #5099830-5
Epirubicin side effect was reported by a Health Professional from AUSTRALIA on Aug 23, 2006. Female patient, 44 years of age, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: bacteraemia, chills, pyrexia, white blood cell count decreased. Epirubicin dosage: unknown. During the same period patient was treated with CYCLOPHOSPHAMIDE, FLUOROURACIL, TRIPTORELIN ACETATE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5223018-8
Epirubicin side effect was reported by a Consumer or non-health professional from JAPAN on Jan 17, 2007. Female patient, weighting 112.4 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: hepatic function abnormal, interstitial lung disease, pyrexia, vasculitis , white blood cell count decreased. Epirubicin dosage: DAILY DOSE:39MG-FREQ:DAILY. During the same period patient was treated with TAXOTERE, TAMOXIFEN CITRATE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #5267710-8
Epirubicin side effect was reported by a Consumer or non-health professional from JAPAN on Mar 06, 2007. Female patient, weighting 112.4 lb, was diagnosed with breast cancer  and was treated with Epirubicin. After drug was administered, patient experienced the following side effects: hepatic function abnormal, interstitial lung disease, pyrexia, vasculitis , white blood cell count decreased. Epirubicin dosage: DAILY DOSE:39MG. During the same period patient was treated with TAXOTERE, TAMOXIFEN CITRATE. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4677165-X
Epirubicin side effect was reported by a Health Professional from on May 16, 2005. Male patient, 64 years of age, weighting 172.0 lb, was treated with Epirubicin. After drug was administered, patient experienced the following side effects: hyperhidrosis, hypocalcaemia, neutrophil count decreased, ph body fluid abnormal, productive cough, pyrexia, white blood cell count decreased. Epirubicin dosage: (100 MG) INTRAVENOUS. During the same period patient was treated with CISPLATIN, CAPECITABINE, METOCLOPRAMIDE, DEXAMETHASONE, TINZAPARIN, ENOXAPARIN. Patient was hospitalized. Patient recovered.

Epirubicin Side Effects Report #4698076-X
Epirubicin side effect was reported by a Health Professional from on May 16, 2005. Male patient, 64 years of age, weighting 172.0 lb, was treated with Epirubicin. After drug was administered, patient experienced the following side effects: blood ph abnormal, hyperhidrosis, hypocalcaemia, neutrophil count decreased, productive cough, pyrexia, white blood cell count decreased. Epirubicin dosage: (100 MG) INTRAVENOUS. During the same period patient was treated with CISPLATIN, CAPECITABINE, METOCLOPRAMIDE, DEXAMETHASONE, TINZAPARIN, ENOXAPARIN. Patient was hospitalized. Patient recovered.